Biocept Liquid Biopsy ROS1 Assay

Jan 20, 2015

Biocept announced it has launched a blood-based ROS1 rearrangement test for non-small cell lung cancer patients. The assay, which will be performed at the firm's CLIA-certified and CAP-accredited laboratory, detects ROS1 rearrangements in circulating tumor cells in order to determine if NSCLC patients might benefit from molecularly targeted drugs.

Breaking News

Oxford Nanopore, Geneyx to Develop Software for Clinical Nanopore Sequencing
New Products Posted to GenomeWeb: ASMS Roundup, Bionano Genomics, Parse Biosciences, BioEcho
People in the News at Biocartis, Angle, Nucleix, Almaden Genomics, SomaLogic, More
GWAS Links Human Voice Pitch to Gene Influencing Cardiovascular, Hormonal Processes
T2 Biosystems, Vanderbilt University Medical Center Partner on Prospective Bacterial Sepsis Dx Study

The Scan

Foxtail Millet Pangenome, Graph-Based Reference Genome

Researchers in Nature Genetics described their generation of a foxtail millet pangenome, which they say can help in crop trait improvement.

Protein Length Distribution Consistent Across Species

An analysis in Genome Biology compares the lengths of proteins across more than 2,300 species, finding similar length distributions.

Novel Genetic Loci Linked to Insulin Resistance in New Study

A team reports in Nature Genetics that it used glucose challenge test data to home in on candidate genes involved in GLUT4 expression or trafficking.

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.